<!DOCTYPE html>
<html>

<head>
  <title>Multiple Visualisations | An Example</title>
  <!-- Import Vega & Vega-Lite (does not have to be from CDN) -->
  <script src="https://cdn.jsdelivr.net/npm/vega@5.20.2"></script>
  <script src="https://cdn.jsdelivr.net/npm/vega-lite@5.1.0"></script>
  <script src="https://cdn.jsdelivr.net/npm/vega-embed@6.17.0"></script>

  <!-- Import pure.css -->
  <link rel="stylesheet" href="https://unpkg.com/purecss@2.0.3/build/pure-min.css"
    integrity="sha384-cg6SkqEOCV1NbJoCu11+bm0NvBRc8IYLRGXkmNrqUBfTjmMYwNKPWBTIKyw9mHNJ" crossorigin="anonymous">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <!-- Google font -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Open+Sans&display=swap" rel="stylesheet">

  <!-- CSS file -->
  <link rel="stylesheet" type="text/css" href="style.css" media="all">

  <style type="text/css">
      div{
        margin: auto;
      }
  </style>
</head>

<body >   
  <div class="color-bar">
        Monash Medical Centre
    </div>
    
    <!-- end pure grid group -->
    <div class="vis-container" >
      <div class="vis-container">
        <h2 style="font-size: 36px; color:#1c9099 ;">The Variation Between Clinicians and Hospitals</h2>
          <div class="container">
        <p style="background-color: #F1F1F1;">
            In the report, the analysis will focus on different treatment orders by examining the distribution of the number of patients seen and their corresponding percentages for each individual clinician. The dataset records child patients that are less than 12 months of age, presentng to ED with respiratory illness from 2015 to 2016.The objective is to investigate how variation is displayed at both the clinician and hospital levels. Users can interact with the scatter plots by zooming in and out. Additionally, if there is a specific clinician ID available, the "Search for Clinician" feature can be used to target that clinician's data. If the visualization layout appears too spread out, adjusting the zoom settings on the PC can provide a better view.
        </p>
    </div>
    
  
        </div>
      </div>
      <div class="pure-g">
        <div class="pure-u-1-2">
          <div class="center">
              <div id="vis1" class="vis-container"></div>
          </div>
        </div>

        <div class="pure-u-1-2">
          <div class="center">
              <div id="vis2" class="vis-container"></div>
          </div>
        </div>
      </div>

      

      <div class="vis-container" >
        <div class="vis-container">
        
          <div class="container">

            <div id="vis19" class="vis-container"></div>
            <p>In the Chloral Hydrate visualisation, the violin plot reveals several insights:</p>
        <ul>
            <li style="text-align: left;">Dandenong: No Chloral Hydrate use.</li>
            <li style="text-align: left;">MMC-Clayton: Low usage despite more clinicians, all under 8%, indicating cautious use.</li>
            <li style="text-align: left;">Casey: Few outliers in usage with fewer patients seen, but overall reasonable.</li>
        </ul>
            <p>Summary: MMC and Dandenong are cautious, Casey shows reasonable use with minor outliers.</p>
    </div>
        </div>
        <div class="pure-g">
          <div class="pure-u-1-2">
            <div class="center">
                <div id="vis3" class="vis-container"></div>
            </div>
          </div>
  
          <div class="pure-u-1-2">
            <div class="center">
                <div id="vis4" class="vis-container"></div>
            </div>
          </div>
        </div>

        
  

        <div class="container">
           <div id="vis20" class="vis-container"></div>
        <p>Overall, Ibuprofen is widely accessed compared to other medications across all hospitals. As the number of patients seen increases, the percentage of Ibuprofen usage decreases, but there is a lower limit. Notably, this reduction occurs in common intervals, such as 
           
        </p>
    </div>
        <ul>
            <li style="text-align: left;">8% to 10% for Casey and Dandenong</li>
            <li style="text-align: left;">40% across all hospitals</li>
          
        </ul>
          <div class="pure-g">
            <div class="pure-u-1-2">
              <div class="center">
                  <div id="vis5" class="vis-container"></div>
              </div>
            </div>
    
            <div class="pure-u-1-2">
              <div class="center">
                  <div id="vis6" class="vis-container"></div>
              </div>
            </div>
          </div>

          
       <div class="container">
          <div id="vis21" class="vis-container"></div>
        <p>
          The violin plot reveals noticeable differences in the shape of Casey and Dandenong compared to MMC-Clayton when it comes to Ondansetron usage:   
        </p>
    </div> 
         
          <ul>
            <li style="text-align: left;class="container"">Casey and Dandenong: Both Casey and Dandenong exhibit more prominent outliers in their Ondansetron usage data. This contributes to a steeper shape in their respective violin plots.</li>
            <li style="text-align: left;class="container"">MMC-Clayton: In contrast, MMC-Clayton appears to have a less steep shape and fewer outliers, suggesting that MMC-Clayton generally follows stricter guidelines or practices when it comes to Ondansetron usage.</li>
    <div class="container">
        <p>
         In summary, the violin plot indicates that MMC-Clayton tends to have a more restrained and consistent approach to Ondansetron usage compared to Casey and Dandenong, which have more noticeable outliers and variation in their usage patterns, but still lie in reasonable range.
  
        </p>
    </div>
          
         
        </ul>
            <div class="pure-g">
              <div class="pure-u-1-2">
                <div class="center">
                    <div id="vis7" class="vis-container"></div>
                </div>
              </div>
      
              <div class="pure-u-1-2">
                <div class="center">
                    <div id="vis8" class="vis-container"></div>
                </div>
              </div>
            </div>

            

        <div class="container">
           <div id="vis22" class="vis-container"></div>
        <p>
           The violin plot shows that Paracetamol is commonly used in all hospitals, with consistent trends: 
        </p>
    </div> 
         
          <ul>
            <li style="text-align: left;class="container"">Paracetamol is widely accessed across all hospitals.
</li>
            <li style="text-align: left;class="container"">There is a noticeable reduction in usage percentages in a range roughly between 8% and 40% across all hospitals.</li>
        <div class="container"> 
        <p>
            This suggests that there may be guidelines or practices in place across these hospitals that result in a consistent pattern of Paracetamol usage.
        </p>
    </div>

            
              <div class="pure-g">
                <div class="pure-u-1-2">
                  <div class="center">
                      <div id="vis9" class="vis-container"></div>
                  </div>
                </div>
        
                <div class="pure-u-1-2">
                  <div class="center">
                      <div id="vis10" class="vis-container"></div>
                  </div>
                </div>
              </div>

             
      <div class="container">

          <div id="vis23" class="vis-container"></div>
        <p> In the usage of prednisolone, there are outliers among clinicians in all hospitals that exhibit a common characteristic: they are evenly spread out across a particular range of percentage values. This suggests that there may be specific scenarios or conditions where prednisolone is prescribed by clinicians in a consistent manner, leading to these evenly distributed outliers across hospitals.
           
        </p>
    </div>

              
                <div class="pure-g">
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis11" class="vis-container"></div>
                    </div>
                  </div>
          
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis12" class="vis-container"></div>
                    </div>
                  </div>
                </div>

             
      <div class="container">

            <div id="vis24" class="vis-container"></div>
            <p>It is apparent that Casey exhibits less variation in the usage of Salbutamol compared to Dandenong and MMC-Clayton. Specifically:</p>
        <ul>
           
            <li style="text-align: left;">Casey has a shorter and less pronounced "steeple" shape in the violin plot, indicating a more consistent pattern of Salbutamol usage.
</li>
            <li style="text-align: left;">Within the violin plot, Casey has more data points clustered in the middle of the plot, suggesting a concentration of usage percentages around a certain range.
</li>
        </ul>
            <p>This suggests that while Dandenong and MMC-Clayton may have more variability and outliers in their Salbutamol usage, Casey maintains a more uniform and concentrated pattern of usage for this medication.
</p>
    </div>
   
     


      <div class="pure-g">
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis13" class="vis-container"></div>
                    </div>
                  </div>
          
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis14" class="vis-container"></div>
                    </div>
                  </div>
                </div>

            
      <div class="container">

            <div id="vis25" class="vis-container"></div>
            <p>It is apparent that Casey exhibits less variation in the usage of Salbutamol compared to Dandenong and MMC-Clayton. Specifically:</p>
        <ul>
           
            <li style="text-align: left;">Casey has a shorter and less pronounced "steeple" shape in the violin plot, indicating a more consistent pattern of Salbutamol usage.
</li>
            <li style="text-align: left;">Within the violin plot, Casey has more data points clustered in the middle of the plot, suggesting a concentration of usage percentages around a certain range.
</li>
        </ul>
            <p>This suggests that while Dandenong and MMC-Clayton may have more variability and outliers in their Salbutamol usage, Casey maintains a more uniform and concentrated pattern of usage for this medication.
</p>
    </div>

             <div class="pure-g">
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis15" class="vis-container"></div>
                    </div>
                  </div>
          
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis16" class="vis-container"></div>
                    </div>
                  </div>
                </div>

              
      <div class="container">

            <div id="vis26" class="vis-container"></div>
            <p>It is apparent that Casey exhibits less variation in the usage of Salbutamol compared to Dandenong and MMC-Clayton. Specifically:</p>
        <ul>
           
            <li style="text-align: left;">Casey has a shorter and less pronounced "steeple" shape in the violin plot, indicating a more consistent pattern of Salbutamol usage.
</li>
            <li style="text-align: left;">Within the violin plot, Casey has more data points clustered in the middle of the plot, suggesting a concentration of usage percentages around a certain range.
</li>
        </ul>
            <p>This suggests that while Dandenong and MMC-Clayton may have more variability and outliers in their Salbutamol usage, Casey maintains a more uniform and concentrated pattern of usage for this medication.
</p>
    </div>

             <div class="pure-g">
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis17" class="vis-container"></div>
                    </div>
                  </div>
          
                  <div class="pure-u-1-2">
                    <div class="center">
                        <div id="vis18" class="vis-container"></div>
                    </div>
                  </div>
                </div>

              
      <div class="container">

            <div id="vis27" class="vis-container"></div>
            <p>It is apparent that Casey exhibits less variation in the usage of Salbutamol compared to Dandenong and MMC-Clayton. Specifically:</p>
        <ul>
           
            <li style="text-align: left;">Casey has a shorter and less pronounced "steeple" shape in the violin plot, indicating a more consistent pattern of Salbutamol usage.
</li>
            <li style="text-align: left;">Within the violin plot, Casey has more data points clustered in the middle of the plot, suggesting a concentration of usage percentages around a certain range.
</li>
        </ul>
            <p>This suggests that while Dandenong and MMC-Clayton may have more variability and outliers in their Salbutamol usage, Casey maintains a more uniform and concentrated pattern of usage for this medication.
</p>
    </div>


        
      
  





  

      
  <script type="text/javascript">
    var specVis1 = "./scatter_ch.json";
    var specVis2 = "./scatter_ch_search.json";
    var specVis3 = "./scatter_ibuprofen.json";
    var specVis4 = "./scatter_ibuprofen_search.json";
    var specVis5 = "./scatter_ondansetron.json";
    var specVis6 ="./scatter_ondansetron_search.json";
    var specVis7 = "./scatter_paracetamol.json";
    var specVis8 = "./scatter_paracetamol_search.json";
    var specVis9 = "./scatter_prednisolone.json";
    var specVis10 = "./scatter_prednisolone_search.json";
    var specVis11 = "./scatter_salbutamol.json";
    var specVis12 = "./scatter_salbutamol_search.json";
    var specVis13 = "./scatter_pred_dexa.json";
    var specVis14 = "./scatter_pred_dexa_search.json";
    var specVis15 = "./scatter_sal_ipra.json";  
    var specVis16 = "./scatter_sal_ipra_search.json";
    var specVis17 = "./scatter_xray.json";
    var specVis18 ="./scatter_xray_search.json";
    var specVis19 = "./barchart_ch.json";
    var specVis20 = "./barchart_ibuprofen.json";
    var specVis21 = "./barchart_ondansetron.json";
    var specVis22 = "./barchart_paracetamol.json";
    var specVis23 = "./barchart_prednisolone.json";
    var specVis24 = "./barchart_salbutamol.json";
    var specVis25 = "./barchart_prednisolonedexamethasone.json";
    var specVis26 = "./barchart_salbutamolipratropium.json";
    var specVis27 = "./barchart_XR Chest X-ray.json";

    vegaEmbed('#vis1', specVis1, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis2', specVis2, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis3', specVis3, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis4', specVis4, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis5', specVis5, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);
    vegaEmbed('#vis6', specVis6, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis7', specVis7, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis8', specVis8, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis9', specVis9, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis10', specVis10, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis11', specVis11, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis12', specVis12, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis13', specVis13, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis14', specVis14, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis15', specVis15, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis16', specVis16, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis17', specVis17, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);
    vegaEmbed('#vis18', specVis18, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis19', specVis19, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis20', specVis20, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis21', specVis21, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis22', specVis22, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis23', specVis23, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis24', specVis24, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis25', specVis25, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis26', specVis26, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

    vegaEmbed('#vis27', specVis27, { "actions": false }).then(function (result) {
      // Access the Vega view instance (https://vega.github.io/vega/docs/api/view/) as result.view
    }).catch(console.error);

  </script>
</body>

</html>




  
